MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Comparing neuromelanin intensity estimation techniques for Parkinson’s disease image analysis

    V. Madge, V. Fonov, A. Bailey, A. Dagher, E. Fon, R. Postuma, DL. Collins (Montréal, Canada)

    Objective: The objective of this study is to compare robust neuromelanin (NM) substantia nigra pars compacta (SN) and locus coeruleus (LC) quantification techniques captured in…
  • 2023 International Congress

    Accelerated longitudinal brain atrophy in the ‘diffuse malignant’ Parkinson’s disease subtype

    SM. Fereshtehnejad, R. Moqadam, R. Postuma, M. Dadar, Y. Zeighami (Ottawa, Canada)

    Objective: To investigate differential pattern of brain atrophy between Parkinson’s disease (PD) clinical subtypes using longitudinally acquired brain magnetic resonance imaging (MRIs). Background: Parkinson’s disease…
  • 2023 International Congress

    Verbal Fluency Changes After Unilateral STN Deep Brain Stimulation in Parkinson’s Disease: A Connectomics-Based Approach

    MJ. Kim, I. Zuccaroli, V. Del Bene, S. Brinkerhoff, R. Martin, J. Olson, M. Nelson, C. Gonzalez, V. Kamath, J. Bentley, B. Guthrie, R. Knight, H. Walker, K. Mills (Baltimore, USA)

    Objective: To investigate neural circuitry associated with verbal fluency changes after STN-DBS in Parkinson’s disease. Background: Despite its substantial motor benefits, subtle cognitive changes can…
  • 2023 International Congress

    Adequate hydration with personalized diet improves bowel function and mobility for people with Parkinson’s (PwP’s) on levodopa/carbidopa intestinal gel (LCIG) infusion therapy

    Y. Ben Mordechai, S. Israeli-Korn, O. Cohen, S. Hassin-Baer (Tel Hashomer, Israel)

    Objective: To investigate the effect of the adequate hydration with personalized diet on bowel function, motor function, and global function in PwP’s on LCIG. Background:…
  • 2023 International Congress

    Gait during turning associates with imbalance and falls in PD: 3D Video based analysis from a single camera

    JH. Shin, HY. Jeon, B. Jin, SM. Lee, KA. Woo, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: This study aimed to investigate the relationship between gait parameters during turning and postural imbalance and falls in Parkinson's disease (PD). Background: It is…
  • 2023 International Congress

    Integrating care coordination into telemedicine services provides a better patient experience than care coordination alone: Insights from a national neurodegenerative disease telemedicine program

    J. Hatcher-Martin, C. Byrne, E. Anderson (Chicago, USA)

    Objective: To develop a comprehensive model of remote care for patients diagnosed with Parkinson’s disease (PD). Background: Recent data suggests that the incidence of new…
  • 2023 International Congress

    Why Me Why Not? Understanding the Perception of Research among African Americans with PD

    C. Branson, J. Luc-Rolland, D. Geiger, J. Cook, A. Willis (Atlanta, USA)

    Objective: To recognize the barriers of participating in PD research with qualitative and quantitative data. Background: Women, minorities, and people over 70 years of age…
  • 2023 International Congress

    Safety of foslevodopa/foscarbidopa during optimization and maintenance treatment: Post hoc analysis of a phase 3, single-arm trial

    D. Kern, S. Isaacson, S. Dhanani, J. Aldred, B. Bergmans, D. Santos-Garcia, T. Oeda, F. Gandor, P. Kukreja, L. Bergmann, R. Gupta, S. Talapala, A. Spiegel, T. Kimber (Aurora, USA)

    Objective: Evaluate the frequency of adverse events over time with foslevodopa/foscarbidopa (LDP/CDP) in patients with advanced Parkinson’s disease (PD) in a phase 3, open-label safety…
  • 2023 International Congress

    The long and short of contemporary parkinsonism survival: A 47-year clinicopathological study

    E. Noyes, AH. Rajput, A. Rajput (Saskatoon, Canada)

    Objective: We report a 47-year survival study of autopsy verified Parkinson syndrome (PS) and Parkinson’s disease (PD) cases. The objectives were: 1) to identify PS…
  • 2023 International Congress

    Disease progression in Parkinson‘s disease patients with Mild Cognitive Impairment: 5-year longitudinal study from The Early Parkinson’s disease Longitudinal Singapore (PALS) cohort

    X. Deng, S. Saffari, S. Ng, N. Chia, X. Choi, D. Heng, B. Xiao, Z. Xu, K. Tay, W. Au, N. Liu, E. Tan, L. Tan (Singapore, Singapore)

    Objective: To investigate motor, non-motor and cognition progression in early PD patients with Mild Cognitive Impairment (MCI) and normal cognition over 5 years.    Background:…
  • « Previous Page
  • 1
  • …
  • 209
  • 210
  • 211
  • 212
  • 213
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • VIT-D and Tics Movement Disorder
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley